Stakeholder: The US Federal Government
The Legislative Branch
The US Federal Government has mobilized to address the Opioid Epidemic and to provide pain management oversight.
1. The federal opioid-pain ecosystem and stakeholders
2. History of the federal response to the opioid/ pain challenge focus on congress
3. Overview of current efforts and strategies
4. Monitoring the federal effort
5. The war on drugs
6. Checklist for federal agencies and programs
7. Citizen tools box
Content will be in various forms including check list, articles, info-graphs, interviews, links to other websites, videos and other media forms.
Federal Government Opioid Pain Ecosystem and Stakeholders
Overview of current efforts by congress to address the Pain Opioid Epidemic
The Legislative Branch
"I am pleased to transmit the 2014 National Drug Control Strategy, a 21st century approach to drug policy that is built on decades of research demonstrating that addiction is a disease of the brain—one that can be prevented, treated, and from which people can recover. The pages that follow lay out an evidence-based plan for real drug policy reform, spanning the spectrum of effective prevention, early intervention, treatment, recovery support, criminal justice, law enforcement, and international cooperation."
The 2014 National Drug Control Strategy
Presidential Proclamation -- Prescription Opioid and Heroin Epidemic Awareness Week, Sept 2016
The House of Representatives
The Subcommittee on Health, held (October 8th,2015) a hearing entitled, “Examining Legislative Proposals to Combat our Nation’s Drug Abuse Crisis.” Subcommittee members reviewed a series of bipartisan bills to address the growing threat of drug abuse. The Oversight and Investigations Subcommittee has held five hearings over the past year and a half in an effort to better understand state and federal efforts to address this growing and complex crisis happening in communities across the country.
More about the the hearing and congressional efforts
On December 17th, The House Committee on Oversight and Reform, chaired by Rep. Carolyn B. Maloney held “Landmark Hearings with Sackler Family Members and the Purdue Pharma CEO on their Roles in Fueling Opioid Crisis.”
Senate Hearing on Opioid Crisis